National International Holding Company K.S.C.P. (KWSE:NIH)
Kuwait · Delayed Price · Currency is KWD · Price in KWF 0.1910
+0.0040 (2.14%)
At close: Sep 17, 2026
KWSE:NIH Ratios and Metrics
Market cap in millions KWD. Fiscal year is January - December.
Millions KWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 48 | 35 | 80 | 24 | 29 | 32 | |
Market Cap Growth | 40.93% | -56.93% | 233.20% | -15.55% | -10.74% | 83.85% |
Enterprise Value | 49 | 35 | 87 | 28 | 37 | 36 |
Last Close Price | 0.19 | 0.13 | 0.31 | 0.09 | 0.11 | 0.11 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 475.03 | 18.18 | 49.04 | 10.59 | 16.60 | 17.85 |
PS Ratio | 10.76 | 5.26 | 9.84 | 3.04 | 4.18 | 5.47 |
PB Ratio | 0.99 | 0.70 | 1.70 | 0.51 | 0.63 | 0.68 |
P/TBV Ratio | 1.12 | 0.79 | 2.08 | 0.62 | 0.77 | 0.83 |
P/FCF Ratio | - | 18.61 | - | - | - | 35.33 |
P/OCF Ratio | - | 18.48 | - | - | - | 25.33 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 11.14 | 5.31 | 10.70 | 3.53 | 5.38 | 6.21 |
EV/EBITDA Ratio | - | 17.86 | 23.11 | 9.69 | 17.95 | 17.05 |
EV/EBIT Ratio | - | 19.19 | 24.26 | 10.00 | 19.69 | 18.21 |
EV/FCF Ratio | - | 18.76 | - | - | - | 40.09 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.06 | 0.07 | 0.06 |
Debt / EBITDA Ratio | 63.44 | 1.13 | 0.66 | 0.92 | 1.54 | 1.38 |
Debt / FCF Ratio | - | 1.19 | - | - | - | 3.25 |
Net Debt / Equity Ratio | -0.08 | -0.10 | -0.06 | -0.09 | -0.01 | -0.02 |
Net Debt / EBITDA Ratio | -101.97 | -2.57 | -0.78 | -1.54 | -0.31 | -0.48 |
Net Debt / FCF Ratio | 38.27 | -2.70 | 2.50 | 11.12 | 0.74 | -1.12 |
Asset Turnover | 0.08 | 0.12 | 0.15 | 0.14 | 0.12 | 0.11 |
Inventory Turnover | 3.48 | 4.11 | 3.95 | 4.68 | 5.00 | 3.78 |
Quick Ratio | 3.58 | 4.62 | 2.34 | 3.01 | 1.30 | 1.89 |
Current Ratio | 3.89 | 4.95 | 2.52 | 3.25 | 2.03 | 2.95 |
Return on Equity (ROE) | 0.12% | 3.90% | 3.92% | 5.49% | 3.65% | 4.00% |
Return on Assets (ROA) | -0.11% | 2.03% | 4.03% | 3.19% | 2.12% | 2.39% |
Return on Invested Capital (ROIC) | -0.22% | 4.08% | 8.23% | 6.36% | 4.10% | 4.38% |
Return on Capital Employed (ROCE) | -0.20% | 3.40% | 6.90% | 5.30% | 3.80% | 3.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.21% | 5.50% | 2.04% | 9.44% | 6.02% | 5.60% |
FCF Yield | -0.20% | 5.37% | -1.47% | -1.67% | -2.99% | 2.83% |
Dividend Yield | 1027.03% | 1.42% | - | 5.93% | 4.27% | 3.83% |
Payout Ratio | 23.43% | 1.01% | 80.45% | 48.64% | 60.65% | 21.07% |
Buyback Yield / Dilution | 0.51% | -1.03% | -0.29% | -5.02% | -2.86% | 2.25% |
Total Shareholder Return | 1027.54% | 0.40% | -0.29% | 0.91% | 1.42% | 6.08% |